A patient with a moderate asthma exacerbation is receiving supplemental oxygen and has been prescribed systemic corticosteroids. Despite these interventions, the patient's respiratory distress persists with diminished breath sounds and prolonged wheezing. What is the most appropriate next step in the management of this patient's condition?

B) Administer a short-acting beta-agonist (SABA) nebulizer treatment

A) Increase the flow rate of oxygen therapy to 4 liters per minute

B) Administer a short-acting beta-agonist (SABA) nebulizer treatment

C) Initiate intravenous magnesium sulfate for bronchodilation

D) Begin non-invasive positive pressure ventilation (NIPPV)

A nurse is caring for a patient with a moderate exacerbation of asthma. Despite using a rescue inhaler and increased doses of Fluticasone, the patient's oxygen saturation dropped to 89% on room air, and she presents with increased respiratory rate and heart rate. After initiating supplemental oxygen and administering a systemic corticosteroid, the patient's oxygen saturation improved to 94%. Which action should the nurse prioritize next to ensure effective management of this patient's asthma exacerbation?

B) Educate the patient on proper inhaler technique and adherence to the asthma action plan.

A) Continue monitoring the patient's vital signs every four hours.

B) Educate the patient on proper inhaler technique and adherence to the asthma action plan.

C) Prepare the patient for intubation due to persistent wheezing and diminished breath sounds.

D) Contact the healthcare provider to request an increase in oxygen flow rate to 4 liters per minute.

A patient with asthma is receiving systemic corticosteroids and a long-acting beta-agonist. She shows improvement in respiratory rate, heart rate, and oxygen saturation. However, she develops a productive cough with thick, yellow sputum. Which nursing intervention should be prioritized to address this new symptom?

B) Initiate chest physiotherapy to aid in mucus clearance

A) Increase the frequency of bronchodilator treatments

B) Initiate chest physiotherapy to aid in mucus clearance

C) Encourage increased oral fluid intake to thin secretions

D) Administer an antitussive to suppress the cough

A patient with asthma is showing signs of improvement after treatment with systemic corticosteroids and a long-acting beta-agonist. However, she now presents with a productive cough and thick, yellow sputum. Which of the following nursing interventions is most appropriate to address this new symptom while awaiting sputum culture results?

B) Educate the patient on effective coughing and deep breathing techniques.

A) Increase the frequency of nebulizer treatments to help clear the mucus.

B) Educate the patient on effective coughing and deep breathing techniques.

C) Administer a higher dose of corticosteroids to manage potential infection.

D) Discontinue the long-acting beta-agonist to prevent further airway irritation.

A patient with asthma and a secondary bacterial infection caused by Haemophilus influenzae has been prescribed cefuroxime. The latest chest X-ray shows areas of atelectasis in the right lower lobe. Which nursing intervention is most appropriate to address the atelectasis and support the patient's respiratory status?

C) Educate the patient on the importance of using incentive spirometry regularly

A) Encourage the patient to increase fluid intake to thin secretions

B) Administer oxygen therapy to maintain oxygen saturation levels

C) Educate the patient on the importance of using incentive spirometry regularly

D) Instruct the patient to use a humidifier to moisten the airways

A patient with asthma has been diagnosed with a secondary bacterial infection caused by Haemophilus influenzae and is on cefuroxime. The latest chest X-ray reveals atelectasis in the right lower lobe. Which nursing intervention is most appropriate to address the atelectasis and support the patient's recovery?

B) Encourage the use of an incentive spirometer regularly.

A) Increase the frequency of oral fluids to thin mucus secretions.

B) Encourage the use of an incentive spirometer regularly.

C) Advise the patient to rest and decrease physical activity to conserve energy.

D) Recommend a high-protein diet to enhance immune function.

A patient with asthma and a recent lung infection is experiencing increased shortness of breath and wheezing despite an albuterol nebulizer treatment. The arterial blood gas analysis shows a pH of 7.35, PaCO2 of 47 mmHg, and PaO2 of 58 mmHg. Which nursing intervention is most appropriate to address the patient's current respiratory status?

B) Initiate supplemental oxygen therapy to increase oxygen saturation

A) Increase the frequency of albuterol nebulizer treatments

B) Initiate supplemental oxygen therapy to increase oxygen saturation

C) Encourage the use of the incentive spirometer more frequently

D) Prepare the patient for immediate intubation and mechanical ventilation

A patient with asthma and recent infection is experiencing increased shortness of breath and wheezing, with ABG results showing respiratory acidosis. What is the priority nursing intervention to address the patient's current condition?

C) Administer supplemental oxygen to improve oxygenation and reduce respiratory distress.

A) Increase the frequency of incentive spirometer use to improve lung expansion.

B) Encourage oral fluid intake to thin mucus secretions and improve clearance.

C) Administer supplemental oxygen to improve oxygenation and reduce respiratory distress.

D) Prepare the patient for immediate intubation to secure the airway.

A patient with asthma exacerbation and suspected superimposed bacterial infection is showing signs of increasing respiratory distress despite current treatment. As a nurse, which intervention should be prioritized to address the patient's immediate respiratory needs?

A) Initiate high-flow oxygen therapy to improve oxygenation.

B) Prepare the patient for immediate intubation and mechanical ventilation.

C) Administer an increased dose of bronchodilator therapy.

D) Obtain a sputum culture to identify the causative organism.

A patient with asthma exacerbation and suspected superimposed bacterial infection is experiencing increased respiratory distress despite receiving 4 liters of oxygen via nasal cannula and bronchodilator therapy. Her respiratory rate is 30 breaths per minute, and oxygen saturation is 88%-90%. What is the nurse's priority action to address the patient's respiratory status?

D) Position the patient in high Fowler's position to improve ventilation.

A) Increase the oxygen flow rate to 6 liters per minute.

B) Administer the next scheduled dose of bronchodilator early.

C) Prepare for possible intubation and mechanical ventilation.

D) Position the patient in high Fowler's position to improve ventilation.

asthma exacerbation - Nursing Case Study

Pathophysiology

• Primary mechanism: Airway inflammation - Asthma exacerbations are primarily triggered by inflammation of the airways, causing the lining to swell and produce excess mucus. This narrows the air passages, leading to difficulty in breathing and wheezing.

• Secondary mechanism: Bronchoconstriction - In response to inflammatory mediators, the smooth muscles surrounding the airways constrict, further narrowing the airways and increasing resistance to airflow. This results in increased respiratory effort and decreased oxygen exchange.

• Key complication: Airway hyperresponsiveness - Exacerbations can heighten the airways' sensitivity to various triggers, such as allergens or irritants, potentially leading to more frequent and severe future attacks.

This focused understanding of asthma exacerbation mechanisms can aid in targeted nursing interventions and patient education.

Patient Profile

Demographics:

34-year-old female, school teacher

History:

• Key past medical history: Asthma diagnosed at age 10, seasonal allergic rhinitis, and eczema

• Current medications: Albuterol inhaler as needed, Fluticasone inhaler 100 mcg twice daily, Cetirizine 10 mg daily

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Increased shortness of breath and wheezing

• Key symptoms: Persistent cough, chest tightness, fatigue, difficulty sleeping due to breathing issues, mild anxiety

• Vital signs: Temperature 99.1°F, heart rate 110 bpm, respiratory rate 24 breaths per minute, blood pressure 138/88 mmHg, oxygen saturation 92% on room air

Section 1

Change in Patient Status:

Following the initial assessment, the patient's condition began to evolve, indicating a moderate exacerbation of her asthma. Despite administration of her rescue inhaler and increased use of the Fluticasone inhaler, her symptoms persisted and slightly worsened over the next few hours. The patient's respiratory rate increased to 28 breaths per minute, and her oxygen saturation dropped to 89% on room air, indicating a further decline in her respiratory function. Her heart rate also elevated to 118 bpm, suggesting increased compensatory effort due to hypoxia. She reported increased fatigue and expressed feeling more anxious, as breathing became more labored and challenging.

In response to these changes, the healthcare team initiated supplemental oxygen therapy via nasal cannula at 2 liters per minute, which improved her oxygen saturation to 94%. However, auscultation revealed diminished breath sounds with prolonged expiratory wheezes across all lung fields, indicating persistent bronchoconstriction and mucus plugging. The patient's chest X-ray, ordered to rule out any secondary complications such as pneumonia, showed hyperinflation of the lungs but no infiltrates or signs of infection. A complete blood count was conducted, revealing a slight elevation in eosinophils, consistent with an allergic response, further supporting the inflammatory nature of her exacerbation.

These findings prompted a reconsideration of her management plan, as her current regimen appeared insufficient in addressing the severity of her symptoms. The team decided to escalate treatment by administering a systemic corticosteroid, such as prednisone, to rapidly reduce airway inflammation. Additionally, they considered introducing a long-acting beta-agonist (LABA) in combination with her inhaled corticosteroid to provide more sustained bronchodilation. The patient's progress would be closely monitored, with a focus on achieving stabilization and preventing further deterioration. This adjustment in her treatment plan was communicated to the patient, along with education on recognizing early signs of exacerbation and adherence to her asthma action plan to prevent future episodes.

Section 2

Response to Interventions:

After the initiation of systemic corticosteroids and the introduction of a long-acting beta-agonist, the patient's condition began to show signs of improvement. Over the next 24 hours, her respiratory rate gradually decreased to 22 breaths per minute, and her heart rate settled to 102 bpm, indicating a reduction in the compensatory mechanisms previously necessary to manage her hypoxia. Her oxygen saturation on room air rose to 92%, reflecting a positive response to the treatment regimen. The patient reported a slight decrease in her fatigue and anxiety, although she still experienced occasional shortness of breath, particularly during exertion.

A follow-up assessment revealed a moderate improvement in her lung sounds. Auscultation now showed decreased wheezing, particularly in the peripheral lung fields, and her breath sounds were less diminished, suggesting effective bronchodilation and reduced airway obstruction. The healthcare team noted that her mucus production had lessened, which was a positive sign of resolving airway inflammation. A repeat complete blood count showed a slight reduction in eosinophils, aligning with the decreased inflammatory response.

However, despite these improvements, the patient developed a new symptom: a productive cough with thick, yellow sputum. Given the absence of infiltrates on the initial chest X-ray, the team considered the possibility of a secondary infection due to mucus stasis and altered airway clearance. A sputum culture was ordered to identify any bacterial pathogens, and empirical antibiotic therapy was initiated to preemptively address potential infection while awaiting culture results. The clinical team remained vigilant, closely monitoring the patient for any signs of infection or other complications, and continued to emphasize the importance of adherence to her revised asthma management plan.

Section 3

New Diagnostic Results:

After initiating empirical antibiotic therapy, the healthcare team awaited the sputum culture results to determine the specific cause of the patient's productive cough and thick, yellow sputum. Two days later, the laboratory reported the presence of Haemophilus influenzae in the sputum culture, a common bacterial pathogen in respiratory infections, particularly in individuals with underlying chronic conditions like asthma. This finding confirmed the suspected secondary bacterial infection, likely due to mucus stasis and impaired airway clearance. The patient was already receiving a broad-spectrum antibiotic, and based on the culture and sensitivity results, the treatment was adjusted to a more targeted antibiotic, cefuroxime, to effectively combat the identified pathogen.

Simultaneously, a repeat chest X-ray was performed due to the persistence of the productive cough and to ensure no developments of complications such as pneumonia. The X-ray showed no new infiltrates, which was reassuring, but it did reveal areas of atelectasis, particularly in the right lower lobe. This finding suggested that while the infection was being managed, there was still some degree of airway obstruction and collapse of lung tissue, likely from mucus plugging and reduced ventilation. The presence of atelectasis necessitated further interventions, including enhanced chest physiotherapy and the use of bronchodilators, to facilitate the clearance of mucus and promote lung expansion.

The healthcare team recognized the importance of addressing both the infection and the underlying airway issues to prevent further complications. They emphasized the need for the patient to continue her revised asthma management plan, adhere to the antibiotic regimen, and engage in regular breathing exercises to improve lung function. The team scheduled a follow-up appointment to reassess her condition and ensure that the interventions were effective in resolving the infection and enhancing her overall respiratory status. As the patient continued her treatment, the team remained vigilant for any changes in her condition, ready to adjust the plan as necessary to support her recovery.

Section 4

As the patient continued her treatment regimen, the healthcare team closely monitored her condition for any new developments. On the third day post-antibiotic adjustment, the patient reported an increase in shortness of breath and a slight wheeze, suggesting an exacerbation of her asthma symptoms. During the assessment, her vital signs revealed a respiratory rate of 26 breaths per minute, heart rate of 112 beats per minute, and an oxygen saturation of 91% on room air. Auscultation of the lungs indicated diminished breath sounds in the right lower lobe, consistent with the previously noted atelectasis, and scattered wheezes throughout the lung fields.

In response to these findings, the team decided to administer an albuterol nebulizer treatment to provide immediate bronchodilation and improve her breathing. Additionally, the patient's peak expiratory flow rate was measured, showing a significant decline to 55% of her personal best, further confirming the need for intensified management of her asthma. The team emphasized the importance of her using an incentive spirometer to assist in re-expanding the affected lung areas and encouraged her to maintain a high level of hydration to help thin mucus secretions.

Despite these interventions, the patient developed tachypnea and increasing difficulty in clearing secretions, prompting a repeat arterial blood gas analysis. The results showed a pH of 7.35, PaCO2 of 47 mmHg, and PaO2 of 58 mmHg, indicating respiratory acidosis due to hypoventilation and inadequate gas exchange. Recognizing the potential for respiratory failure, the healthcare team initiated supplemental oxygen therapy and considered the need for non-invasive ventilation support. This shift in the patient's status highlighted the complexity of managing concurrent asthma and infection, underscoring the necessity of a dynamic, responsive treatment plan. The team remained vigilant, ready to escalate care if her condition warranted more aggressive interventions.

Section 5

The healthcare team continued to monitor the patient's condition closely, given the recent developments in her respiratory status. Despite the administration of supplemental oxygen and bronchodilator therapy, the patient exhibited signs of increasing respiratory distress. Her respiratory rate escalated to 30 breaths per minute, and she appeared visibly fatigued, with accessory muscle use noted during breathing. The patient's heart rate remained elevated at 118 beats per minute, and her oxygen saturation fluctuated between 88% and 90% on 4 liters of oxygen via nasal cannula. The diminished breath sounds persisted in the right lower lobe, and wheezing was now more pronounced with each auscultation, suggesting worsening airflow limitation.

Recognizing the potential for further complications, the team ordered a chest X-ray to evaluate for any additional pulmonary changes. The imaging revealed an increase in the area of atelectasis in the right lower lobe, accompanied by new infiltrates suggestive of a possible superimposed bacterial infection or worsening of the current infection. Laboratory results showed an elevated white blood cell count of 14,000/mm³, indicating a heightened inflammatory response. In light of these findings, the team considered adjusting the antibiotic regimen to cover a broader range of pathogens, while simultaneously consulting with a pulmonologist for further recommendations on managing the atelectasis and potential infection.

The patient's condition highlighted the intricate interplay between asthma exacerbation and underlying infection, necessitating a multifaceted approach to care. The healthcare team remained vigilant, reassessing her response to the current treatment plan and remaining prepared to escalate care if her respiratory status continued to decline. This situation underscored the importance of comprehensive management strategies that address both the immediate respiratory needs and the underlying infectious processes contributing to her clinical deterioration.